How to Determine Whether to Buy or Build your Digital Health Platform • BrightInsight

Biopharma and medtech executives are faced with a number of complex considerations when developing digital health products. One of those considerations is determining whether to buy or to build your underlying platform infrastructure.

Building your own end-to-end infrastructure significantly delays time-to-market, requires substantial upfront and ongoing resources, and is a competitive disadvantage to maintain and scale across a product portfolio.

Read our white paper on how to launch a scalable digital health platform that meets your company’s needs, including recommendations from executives who are leading digital at top biopharma companies:

Karan Arora, Chief Commercial Digital Officer and Global Vice President, AstraZeneca
Brian Johnson, Director, Digital Health, CSL Behring
Paul Upham, Head of Smart Devices, Roche/Genentech

This white paper also walks readers through the main challenges with building a custom platform:

Scalability and interoperability challenges
Upfront and ongoing costs of developing your own IoT platform
Regulatory, privacy and security compliance